CV19 Lab Testing Dashboard powered by hc1
To support health care providers and public health agencies in responding to the COVID-19 pandemic,
hc1 is leading a coalition of 20K+ lab testing locations to power the CV19 Lab Testing Dashboard.

By cyoder

An Indianapolis medical-software firm is expanding its reach into the fast-growing areas of opioid prescription management and precision medicine, in which treatment is determined in part by genetic testing.

bostic-brad-mug-tech-executive.jpg Bostic recently raised $10 million in venture funding and is launching two cloud-based products this month that will “transform and personalize the way health care is delivered,” said Brad Bostic, who founded the firm in 2011 and is chairman and CEO.

Subscribe to the blog
Previous Post hc1 Expands Focus on Precision Health Solution, Completes Series B Round
Next Post® Breakthrough Precision Health Offering Optimizes Prescribing